PAM rs17154889: Understanding Genetic Links to Type 2 Diabetes
The rs17154889 variant is a single-nucleotide polymorphism located within the PAM gene. Research has linked this variant to an increased risk of type 2 diabetes mellitus, particularly in individuals without retinopathy.
What each genotype means
Typical risk profile
This genotype represents the most common form of the PAM gene variant. Research indicates that individuals with this genotype do not carry the specific risk-associated allele linked to altered insulin secretion and type 2 diabetes risk in this study context.
This is the most common genotype observed across most global populations.
Increased diabetes risk
Carrying one copy of this variant is associated with an increased risk of developing type 2 diabetes, particularly in individuals without retinopathy. This variant may influence how your body processes hormones like insulin, though the overall impact on your health depends on many other genetic and lifestyle factors.
The frequency of this genotype varies significantly by ancestry, being more frequently reported in certain Asian populations.
Elevated diabetes risk
Carrying two copies of this variant is associated with a higher statistical risk for type 2 diabetes compared to those without the variant. Because this gene is involved in the production of amidated hormones, you should focus on standard preventative health measures and discuss any concerns about blood sugar regulation with your healthcare provider.
This genotype is less common than the heterozygous form and its prevalence is highly dependent on your specific ancestral background.
What is rs17154889?
The rs17154889 variant is a specific change in the DNA sequence of the PAM gene. In genetics, a single-nucleotide polymorphism (SNP) like rs17154889 represents a variation at a single position in the genome. This variant is located within the PAM gene, which provides instructions for creating the peptidylglycine alpha-amidating monooxygenase enzyme. Scientists study these variations to understand how small differences in our genetic code might influence susceptibility to complex health conditions. While the presence of a specific SNP does not guarantee the development of a disease, it serves as a marker that researchers use to investigate biological pathways. The study of rs17154889 is part of a broader effort to map the genetic architecture of metabolic health and identify how specific DNA changes might contribute to the risk of developing type 2 diabetes.
The Role of the PAM Gene
The PAM gene encodes an enzyme called peptidylglycine alpha-amidating monooxygenase, which is essential for the maturation of many bioactive hormones and peptides. This enzyme performs a process called amidation, which is a chemical modification necessary for these hormones to become biologically active. In the pancreas, the PAM enzyme plays a critical role in the processing of insulin, the hormone responsible for regulating blood sugar levels. When the PAM enzyme does not function optimally, it can lead to defects in insulin production or secretion. Because insulin regulation is central to maintaining healthy blood glucose levels, variations in the PAM gene that affect its catalytic activity are of significant interest to diabetes researchers. Understanding how PAM influences hormone maturation helps scientists explain the underlying mechanisms that may lead to impaired glucose metabolism in some individuals.
Research and Evidence Strength
The association between PAM variants and type 2 diabetes is supported by observational studies, particularly in specific populations. For instance, research has identified that rs17154889 is linked to an increased risk of type 2 diabetes, with some studies noting this correlation specifically in patients who do not have retinopathy. However, the evidence strength for this specific variant is considered limited. While other coding variants in the PAM gene, such as p.D563G and p.S539W, have been more extensively characterized as loss-of-function alleles that impair insulin secretion, the functional impact of rs17154889 is still being explored. It is important to note that genetic associations are statistical in nature and do not imply a direct cause-and-effect relationship for every individual. Further research is required to fully understand the clinical significance of this variant and how it interacts with other genetic and environmental factors to influence diabetes risk.
Population Frequency
The frequency of the rs17154889 variant varies significantly across different ancestral populations. Genetic variants are rarely distributed uniformly across the globe, and the prevalence of specific alleles often depends on the genetic background of a population. Because of this, the risk associated with a particular SNP may be more pronounced in some groups than in others. Researchers often use large-scale databases to track these frequencies, which helps in designing more inclusive genetic studies. If you are interested in the specific frequency of this variant within your own ancestral group, you may consult public genomic databases like gnomAD. Understanding these population-level differences is a key component of modern genomics, as it helps scientists avoid biases and ensures that findings are applicable to diverse groups of people.
What This Information Means for You
Genetic information regarding variants like rs17154889 is intended for educational purposes and should not be used for medical diagnosis or to make personal health decisions. A genetic association does not mean that you will develop type 2 diabetes, nor does the absence of a risk variant guarantee protection. Many factors, including diet, physical activity, and overall lifestyle, play a much larger role in metabolic health than any single genetic variant. If you have concerns about your risk for diabetes or are interested in how your genetics might influence your health, the best course of action is to speak with a healthcare professional. They can provide personalized guidance based on your family history, clinical symptoms, and standard diagnostic tests. Never change your medication or treatment plan based on genetic test results without first consulting your doctor or pharmacist.
How common is this variant?
The frequency of the rs17154889 variant varies by population, and it is important to consult large-scale genomic databases for specific ancestral data.
Frequently asked questions
Does having the rs17154889 variant mean I will get diabetes?
No. Genetic variants are only one of many factors that influence diabetes risk. Lifestyle, diet, and family history are typically much more significant contributors to your overall health.
Can I use this information to change my diabetes medication?
No. You should never change your medication or treatment plan based on genetic information. Always discuss any changes to your health management with your doctor or pharmacist.
Is the PAM gene involved in other health conditions?
The PAM gene is primarily studied for its role in hormone processing and insulin secretion. Research is ongoing to determine if it plays a role in other metabolic or endocrine traits.
Where can I find more information about my specific genetic results?
If you have received genetic testing results, you should consult with a certified genetic counselor or your primary care physician. They can help you interpret the findings in the context of your personal health history.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17154889?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PAM
This variant in the PAM gene is associated with an increased risk of type 2 diabetes mellitus, with specific associations observed in females and individuals with lower BMI.
This variant in the PAM gene is associated with an increased risk of type 2 diabetes mellitus in the Chinese population.